Brian Hangil Kim MD
Clotting Disorder, Hematologic Oncology, Hemophilia & Bleeding Disorder, Myeloproliferative Disorder Hematology-Oncology
Physician
Join to View Full Profile
350 Engle Street1st Floor Berrie BuildingEnglewood, NJ 07631
Phone+1 201-568-5250
Dr. Kim is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Brian Kim, based in Englewood, NJ, specializes in hematology and oncology, with a focus on urological oncology, hematologic oncology, clotting and bleeding disorders, anemia, low blood counts, and myeloproliferative disorders. He completed his residency in Internal Medicine at Kaiser Permanente Southern California and a fellowship in Hematology and Medical Oncology at Zucker School of Medicine at Hofstra/Northwell. Dr. Kim has published research on topics including hypersensitivity to oxaliplatin. His work on hypersensitivity to oxaliplatin has been cited 55 times, demonstrating his contributions to the field.
Education & Training
Zucker School of Medicine at Hofstra/NorthwellFellowship, Hematology and Medical Oncology, 2005 - 2008
Kaiser Permanente Southern California (Los Angeles)Residency, Internal Medicine, 2001 - 2004
SUNY Upstate Medical UniversityClass of 2001
Certifications & Licensure
CA State Medical License 2002 - Present
NY State Medical License 2005 - 2026
NJ State Medical License 2008 - 2025
American Board of Internal Medicine Hematology- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 12 citationsMechanisms of Tertiary Neurodegeneration after Neonatal Hypoxic-Ischemic Brain Damage.Steven W Levison, Eridan Rocha-Ferreira, Brian H Kim, Henrik Hagberg, Bobbi Fleiss
Pediatric Medicine. 2022-08-28 - 53 citationsHypersensitivity to oxaliplatin: an investigation of incidence and risk factors, and literature review.Brian H. Kim, Thomas Bradley, Julia Tai, Daniel R. Budman
Oncology. 2009-02-25
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
